¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-25
±³À°ÀÏÀÚ : 2020-09-25
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING      
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ,      
Âü¼®¿¹»óÀοø : 2000¸í 
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï : ȸ¿ø:50,000¿ø/ºñȸ¿ø:75,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:25,000´çÀϵî·Ï : ȸ¿ø:75,000¿ø/ºñȸ¿ø:100,000/Fellow-in-training,Resident,Trainee,Student,Nurse,etc:35,000      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ09:00~09:30 Physiology and pathophysiology of the vasopressin-mediated renal water reabsorption  ±ÇÅÂȯ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ09:30~10:00 Single-tubule RNA sequencing and signaling mechanisms in SIADH  ÀÌÀç¿í(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ10:00~10:30 Hydrogen Sulfide Upregulates Renal AQP2 Protein Expression and Promotes Urine Concentration  Chunling Li(Sun Yat-sen University China) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ10:30~11:00 The evolving role of TonEBP as immunometabolic stress protein  ±ÇÇõ¹«(¿ï»ê°úÇбâ¼ú¿ø) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ11:30~12:20 Neuroimmune Control of Inflammation in Acute Kidney Injury  Mark D Okusa(USA) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ12:20~13:10 Uric acid and CKD progression with the review of recent multi-center studies/Uric acid as a mediator of inflammation  ¼Û¿µ¸²¿Ü1ÀÎ(ÇѸ²ÀÇ´ë¿Ü) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ13:10~14:00 Intravenous iron in maintenance dialysis patients  ÃÖÈÆ¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ14:00~14:30 Th17 cells in acute kidney injury: Effects on injury, repair and progression  David Patrick Basile(Indiana University USA) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ14:30~15:00 Pharmacogenomic aspect of steroid resistance in Nephrotic Syndrome (Tentative)  Narayan Prasad(Sanjay Gandhi Postgraduate Institute of Medical Sciences India) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ15:00~15:30 Single-cell transcriptome analysis of kidney diseases  ¹ÚÁöȯ(±¤ÁÖ°úÇбâ¼ú¿ø) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ15:30~16:00 Immuno-pathogenesis and precision medicine in membranous nephropathy  Vivekanand Jha(The George Institute for Global Health India) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ16:00~16:30 Alport syndrome  Kandai Nozu(Japan) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ16:30~17:00 Gitelman syndrome  Nine V.A.M. Knoers(University of Groningen The Netherlands) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ17:00~17:30 Atypical hemolytic uremic syndrome  Á¶Èñ¿¬(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09¿ù 25ÀÏ ¿Â¶óÀΠ17:30~18:00 Diagnosis of Genetic kidney disease  À̹üȸ(¿ï»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN 2020 FULLY VIRTUAL MEETING : 2020-09-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ Á¦28Â÷ ¿¬¼ö°úÁ¤ (½ÉÈ­°úÁ¤) : 2020-09-25
´ÙÀ½±Û ´ëÇѼҾƳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) 2020³âµµ Á¦3Â÷ Á¤±âÁý´ãȸ : 2020-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
527 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ECHO SEOUL 2018 : 2018-09-14 0 539 2018-08-22
526 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-14 0 886 2018-08-22
525 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ µÎÅ뿬±¸È¸ ÇмúÁý´ãȸ : 2018-09-14 0 828 2018-08-22
524 ÀüºÏ ´ëÇÑÀÇ»çÇùȸ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (2Â÷) : 2018-09-14 0 1,713 2018-08-22
523 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 779 2018-08-22
522 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Practical Disaster Preparedness - from Evidence to Practice : 2018-09-13 0 886 2018-08-22
521 ÀüºÏ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (1Â÷) : 2018-09-13 0 1,117 2018-08-22
520 °æ±â °í·Á´ëÇб³ ¾È»êº´¿ø ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¦77Â÷ ¿ù·ÊÁý´ãȸ : 2018-09-13 0 1,010 2018-08-22
519 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-13 0 496 2018-08-22
518 ºÎ»ê ´ëÇÑ°ñ´ë»çÇÐȸ 2018³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Á¦2Â÷ Áý´ãȸ : 2018-09-12 0 714 2018-08-22
517 ±¤ÁÖ Á¶¼±´ëº´¿ø Á¦ 157Â÷ ´ëÇÑÇǺΰúÇÐȸ È£³²Áöȸ : 2018-09-12 0 815 2018-08-22
516 ÀÎõ ÀÎõ¼º¸ðº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦39Â÷ ÀÎõÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-12 0 2,777 2018-08-22
515 ÀÎõ ±æº´¿ø Çѱ¹¿©ÀÚÀÇ»çȸ ºñŸ¹ÎDÀÇ ÀÌÇØ¿Í ÀÓ»óÀû¿ë : 2018-09-12 0 1,437 2018-08-22
514 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø À̺ñÀÎÈÄ°ú Çù·Âº´ÀÇ¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-11 0 1,095 2018-08-22
513 °æ±â °í·Á´ë¾È»êº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦ 60Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-11 0 1,784 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷